Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

Experts and lawmakers are beginning to call for extraordinary measures to alleviate medical shortages that could cripple the U.S. response to the coronavirus.

Why it matters: These shortages affect both testing and treatment, and if they persist, could also thin the ranks of health care workers able to help treat coronavirus patients. And the only solution may be for the federal government to get involved.

Driving the news: Invoking the Defense Production Act was on a list of options included in a 100-page federal government coronavirus response plan, dated from Friday, reported on by the New York Times last night.

  • The law, passed in 1950, gives the president enormous power to force American manufacturers to produce critical supplies.

What they're saying: Some lawmakers at the federal and local level had already called for the federal government to increase its manufacturing capacity.

  • Mark Levin, chair of the New York City Council's health committee, tweeted yesterday that he's "BEGGING, PLEADING that the fed gov't mobilize production and distribution of medical supplies and equipment."
  • "I urge you to immediately exercise the powers authorized to you by the Defense Production Act (DPA) in order to address impending shortages of critical resources in response to the COVID-19 pandemic," Sen. Bob Mendendez wrote in a letter to President Trump yesterday.

Where it stands: The U.S. is likely to face several key shortages in even a moderate outbreak.

  • Labs will need more of some key ingredients for diagnostic tests, including RNA-extraction kits, reagents and swabs. Staying on top of testing is essential to ultimately controlling the outbreak.
  • States are already sounding the alarm over inadequate supplies of protective gear, such as masks, gloves and gowns, for health care workers.
  • "If we run out of those, we’re hosed. Because then doctors and nurses are going to have a choice between not caring for a sick patient, and putting themselves at risk," said Ashish Jha, the director of Harvard's Global Health Institute.
  • Ventilators to help patients breathe are also in short supply. We have about 62,000, and only a limited ability to tap other supplies.

Doctors in Italy are making difficult decisions every day about how to ration their limited supply of ventilators, the WSJ reports.

The Food and Drug Administration "is in close contact with [personal protective equipment] manufacturers to understand their supply capabilities during this outbreak. We have heard about challenges throughout the supply chain that are presently impacting the availability of PPE products, however, we are taking steps to mitigate shortages that healthcare facilities are already experiencing," the agency said in a statement.

The bottom line: “The worst case scenario in that case is we produce a lot of stuff we don’t end up needing...if we don’t do it, we have a lot of people who die unnecessarily," Jha said.

Go deeper

N.Y. Times faces culture clashes as business booms

Illustration: Sarah Grillo/Axios

New York Times columnist David Brooks' resignation from a paid gig at a think tank on Saturday is the latest in a flurry of scandals that America's biggest and most successful newspaper company has endured in the past year.

Driving the news: Brooks resigned from the Aspen Institute following a BuzzFeed News investigation that uncovered conflicts of interest between his reporting and money he accepted from corporate donors for a project called "Weave" that he worked on at the nonprofit.

America rebalances its post-Trump news diet

Illustration: Annelise Capossela/Axios

Nearly halfway through President Biden's first 100 days, data shows that Americans are learning to wean themselves off of news — and especially politics.

Why it matters: The departure of former President Trump's once-ubiquitous presence in the news cycle has reoriented the country's attention.

2021 sees a record number of bills targeting trans youth

Illustration: Annelise Capossela/Axios

Republicans in at least 25 states have introduced over 60 bills targeting transgender children — a legislative boom since January that has beaten 2020's total number of anti-trans bills.

Why it matters: LGBTQ advocates say the unprecedented push was catalyzed by backlash to Biden's election and the Supreme Court ruling that workers cannot be fired for being gay or transgender.